DaVita Kidney Care closed its acquisition of Colorado-based Renal Ventures Management LLC on May 1. DaVita first announced plans to buy RVM in August 2015.
The provider acquired all of RVM’s 38 clinics for $415 million, but the Federal Trade Commission required the company to divest seven centers.
In March, the FTC said DaVita Kidney Care would need to divest its ownership interest in five dialysis clinics in New Jersey and its suburbs and two in the Dallas area to resolve charges that the acquisition is anticompetitive.
Under the settlement, DaVita is barred from contracting with the medical directors of the seven clinics for three years, and it must provide transition services for up to 24 months. The settlement also allows the FTC to appoint a monitor to ensure DaVita’s compliance.
After divestitures, DaVita will add 31 dialysis centers in six states. The company said it is extending employment opportunities to current Renal Ventures clinical personnel and many Renal Ventures business office workers located in Lakewood, Colo.
According to NN&I’s annual dialysis provider ranking, as of July 2015, Renal Ventures had 2,387 dialysis patients, 2,037 of which were in-center, six were home hemodialysis, and 344 were peritoneal dialysis patients.